NEW YORK and LONDON, March 7th, 2017
Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. Gur Roshwalb, Chief Executive Officer, will present at the 29th Annual ROTH Conference on March 14th, 2017, in Dana Point, California. The company is scheduled to present at 8:00 a.m. PST.